Pro-Dex (FRA:PDXN) Total Equity: €39.10 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PDXN Pro-Dex Inc FRA:PDXN
67 GF Score
Price €55.00
GF Value €36.19
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Pro-Dex Total Equity?

Pro-Dex FRA:PDXN +1.85% 67 Total Equity is €39.10 Mil as of Mar. 2026. GuruFocus rates FRA:PDXN with a GF Score™ of 67/100 and a GF Value™ of €36.19 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Pro-Dex's total equity for the quarter that ended in Mar. 2026 was €39.10 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Pro-Dex Total Equity Historical Data

* Premium members only.

The historical data trend for Pro-Dex's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro-Dex Total Equity Chart

Pro-Dex Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.67 24.06 29.16 28.68 31.76

Pro-Dex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.64 31.76 35.37 35.55 39.10
FRA:PDXN
67GF Score
Pro-Dex Inc FRA:PDXN
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pro-Dex Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Pro-Dex's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=53.053-21.294
=31.76

Pro-Dex's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=64.855-25.759
=39.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €39.10 Mil mean?
Pro-Dex (FRA:PDXN) has a Total Equity of €39.10 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Pro-Dex and its competitors.
Is Pro-Dex's Total Equity too high?
Pro-Dex's current Total Equity is €39.10 Mil. Overall, Pro-Dex has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's Total Equity compare to KRMD and EMBC?
Pro-Dex's Total Equity of €39.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Pro-Dex and its competitors. Pro-Dex's current Total Equity is €39.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (FRA:PDXN) is currently considered Significantly Overvalued. The stock's GF Value™ is €36.19, compared to a current price of €55.00 — trading 52% above its estimated fair value. The current Total Equity is €39.10 Mil. Pro-Dex's overall GF Score™ is 67/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current Total Equity is €39.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro-Dex (FRA:PDXN) Overvalued in 2026?

Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued. The current stock price of €55.00 is trading 52% above its estimated GF Value™ of €36.19. GuruFocus considers Pro-Dex to be Significantly Overvalued.

Key valuation signals for FRA:PDXN:

  • Total Equity: €39.10 Mil
  • GF Value™: €36.19 vs. price of €55.00 (52% above fair value)
  • GF Score™: 67/100 with 10 warning signs

No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pro-Dex Business Description

Other Exchanges PDEX:USA
Address 2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
67GF Score

Get the complete analysis for FRA:PDXN

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.00
Price
€36.19
GF Value